Form D · Other Technology
Luyef Biotechnologies Inc
Santiago, F3 · CIK 0001893229
Offering snapshot reported Nov 12, 2021 · SEC filing
- Reported sold
- $200K Offering amount: $200K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $200K Reported outside-investor minimum
- First sale
- Oct 26, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2021 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-420894
Simple Agreement for Future Equity (Safe)
Source: Form D, filed Nov 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kris Elliot Blanchard Tapia | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
Marchant Pereira 150, Of. 1002 Providencia
Santiago, F3, 7500523
Santiago, F3, 7500523